A new study reveals colistin-resistant bacteria in imported shrimp and scallops, posing a public health risk. Researchers found these genes can spread easily via plasmids between bacteria. Most US shrimp is imported, yet screening doesn't catch these resistant strains. The findings highlight gaps in food safety protocols regarding antibiotic resistance.
June 23, 2025
Imported seafood increasing resistance to colistin, a potent antibiotic: Study
"Many people don’t know that
most seafood consumed in the U.S. is imported, including about 90% of
shrimp." — Issmat Kassem
A team of US researchers on
Sunday said it has identified a way that colistin (a potent, last-resort
antibiotic) resistance genes are spreading via imported seafood.
Key Points
1
Colistin-resistant bacteria found in imported shrimp and scallops
2
Resistance genes spread via plasmids between bacteria
3
90% of US shrimp is imported
4
No routine screening for these resistant bacteria
Colistin is used only to treat
people with dangerous, life-threatening bacterial infections that have developed
resistance to other drugs. But it’s not foolproof.
Worldwide, resistance to colistin
is spreading, further diminishing treatment options and putting infected people
at higher risk.
Researchers from the University
of Georgia recently identified a way that colistin resistance genes are
spreading.
In a new study, microbiologist
Issmat Kassem, and his group have reported the first isolation of
colistin-resistance genes in bacteria found in imported shrimp and scallops,
purchased from 8 food markets around Atlanta.
“Many people don’t know that most
seafood consumed in the U.S. is imported, Kassem said, including about 90 per
cent of shrimp.
Imported seafood is screened for
contaminants but the process doesn’t catch everything, especially antimicrobial
resistance genes. “The bacteria that were carrying colistin resistance genes
are not normally screened.”
Kassem and his group also found
that some of the resistance genes are carried on plasmids — round bits of
genetic material that can be transmitted from bacteria to bacteria.
Antimicrobial resistant
infections kill hundreds of thousands of people globally every year, and
antimicrobial resistance is a rising public health menace.
Colistin was first introduced in
the 1950s to treat infections by pathogenic Gram-negative bacteria, but it
takes a heavy toll on patients, including increased risk of damage to the
nerves and kidneys.
It was discontinued in the U.S.
in the 1980s. However, Kassem noted, other countries continued to use it in
agricultural settings, both to treat infections and to promote animal growth.
Colistin was eventually
reintroduced to human medicine because it was one of the few options available
to treat certain bacterial infections. The World Health Organization
categorises colistin as a high priority critically important antibiotic, which
means it is an essential option for treating serious human infections.
Researchers cautioned that the
group identified 1 source of colistin resistance, but there could be other, and
they’re likely spreading.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment